HARRY DOYLE: Open Payments
NPI 1689801730 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,200 in 69 payments from 18 companies in 2025. Trend: 2023 $488 · 2024 $1,041 · 2025 $1,200
Food & beverage: $1,200
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $241 |
| Novo Nordisk Inc | 6 | $123 |
| Phathom Pharmaceuticals, Inc. | 7 | $115 |
| Novartis Pharmaceuticals Corporation | 5 | $109 |
| Axsome Therapeutics, Inc. | 5 | $95 |
| Lilly USA, LLC | 6 | $94 |
| PFIZER INC. | 4 | $87 |
| Inspire Medical Systems, Inc. | 2 | $75 |
| Xeris Pharmaceuticals, Inc. | 3 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $45 |
Products named: VOQUEZNA, LEQVIO, UBRELVY, Auvelity, MOUNJARO, INSPIRE, KEVEYIS, QULIPTA.
Industry payments across TX — which companies pay providers there.
